Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Marilyn Manco-Johnson

Concepts (497)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Hemophilia A
55
2026
147
11.860
 Why?
Factor VIII
35
2024
104
5.880
 Why?
Hemophilia B
14
2026
66
3.380
 Why?
Hemarthrosis
10
2020
22
3.180
 Why?
Protein C
18
2025
53
3.120
 Why?
Venous Thrombosis
14
2024
194
2.580
 Why?
Hemorrhage
27
2024
809
2.540
 Why?
Protein C Deficiency
10
2025
11
2.200
 Why?
Anticoagulants
19
2024
722
2.070
 Why?
Thrombosis
24
2024
393
2.040
 Why?
Joints
7
2026
107
1.980
 Why?
Thrombophilia
16
2022
88
1.930
 Why?
Hemostasis
7
2023
102
1.860
 Why?
Venous Thromboembolism
15
2024
324
1.840
 Why?
Factor IX
9
2016
51
1.640
 Why?
Thromboembolism
11
2016
125
1.620
 Why?
Child, Preschool
85
2026
11787
1.580
 Why?
Child
114
2026
22633
1.570
 Why?
Blood Coagulation
14
2024
268
1.530
 Why?
Infant
75
2026
10034
1.470
 Why?
Coagulants
7
2018
20
1.440
 Why?
Postthrombotic Syndrome
4
2024
13
1.380
 Why?
Adolescent
94
2026
22428
1.380
 Why?
Fibrinogen
8
2024
177
1.280
 Why?
Hemostatics
3
2022
61
1.260
 Why?
Fibrinolysis
6
2013
162
1.200
 Why?
von Willebrand Factor
6
2023
85
1.180
 Why?
Blood Coagulation Tests
13
2016
70
1.120
 Why?
Fibrinolytic Agents
12
2024
291
1.090
 Why?
Afibrinogenemia
5
2024
7
1.030
 Why?
Young Adult
42
2026
14105
0.940
 Why?
Pulmonary Embolism
7
2024
244
0.940
 Why?
Thrombolytic Therapy
6
2024
163
0.930
 Why?
Infant, Newborn
42
2024
6429
0.910
 Why?
Humans
165
2026
144759
0.890
 Why?
Male
99
2026
72315
0.760
 Why?
Antithrombin III Deficiency
4
2021
8
0.750
 Why?
Prospective Studies
28
2025
7990
0.750
 Why?
Joint Diseases
5
2019
62
0.740
 Why?
Blood Coagulation Disorders
5
2021
189
0.730
 Why?
Adult
57
2026
40449
0.710
 Why?
Pregnancy Complications, Hematologic
6
2024
24
0.710
 Why?
Antithrombins
4
2021
70
0.680
 Why?
Quality of Life
8
2022
3185
0.680
 Why?
Pain Measurement
2
2021
552
0.670
 Why?
von Willebrand Disease, Type 1
3
2017
5
0.670
 Why?
Treatment Outcome
28
2025
11679
0.660
 Why?
Factor V
7
2019
26
0.640
 Why?
Female
89
2026
78271
0.630
 Why?
Pain
2
2021
779
0.610
 Why?
Hemorrhagic Disorders
2
2018
10
0.600
 Why?
Registries
8
2025
2385
0.580
 Why?
Severity of Illness Index
10
2026
2925
0.560
 Why?
Purpura Fulminans
2
2016
2
0.560
 Why?
Drug Administration Schedule
9
2024
779
0.550
 Why?
Blood Platelets
5
2025
400
0.540
 Why?
Disseminated Intravascular Coagulation
6
2020
32
0.530
 Why?
Stroke
7
2018
1256
0.520
 Why?
Thrombin
3
2023
166
0.520
 Why?
Antiphospholipid Syndrome
5
2012
33
0.520
 Why?
Catheterization, Central Venous
5
2007
122
0.510
 Why?
Fetus
3
2023
803
0.500
 Why?
Age Factors
13
2024
3333
0.490
 Why?
Tissue Plasminogen Activator
3
2011
244
0.490
 Why?
Primary Prevention
2
2020
220
0.470
 Why?
Surveys and Questionnaires
7
2021
6048
0.470
 Why?
Blood Coagulation Factors
7
2006
55
0.460
 Why?
Risk Factors
26
2025
10779
0.440
 Why?
Population Surveillance
1
2018
485
0.430
 Why?
Case-Control Studies
12
2024
3604
0.430
 Why?
von Willebrand Diseases
2
2011
28
0.420
 Why?
Middle Aged
28
2026
35875
0.420
 Why?
Cerebral Arterial Diseases
5
2016
49
0.400
 Why?
Hyperhomocysteinemia
1
2013
27
0.400
 Why?
Methylenetetrahydrofolate Reductase (NADPH2)
1
2013
35
0.390
 Why?
Isoantibodies
5
2016
57
0.390
 Why?
Heparin
7
2005
244
0.390
 Why?
Apoprotein(a)
1
2013
8
0.390
 Why?
Sucrose
1
2013
112
0.380
 Why?
Half-Life
3
2022
151
0.370
 Why?
Lipoprotein(a)
1
2013
68
0.360
 Why?
Brain Ischemia
5
2016
358
0.340
 Why?
Point Mutation
5
2008
243
0.340
 Why?
Blood Component Transfusion
3
2010
103
0.340
 Why?
Fibrinolysin
1
2011
19
0.330
 Why?
Aged
18
2026
25913
0.320
 Why?
Blood Loss, Surgical
1
2011
112
0.320
 Why?
Pregnancy
14
2024
7190
0.320
 Why?
United States
18
2025
15966
0.320
 Why?
Asphyxia Neonatorum
1
2010
18
0.310
 Why?
Range of Motion, Articular
3
2024
421
0.310
 Why?
Lupus Coagulation Inhibitor
3
1999
6
0.310
 Why?
Biomarkers
8
2020
4271
0.300
 Why?
Reproducibility of Results
9
2021
3409
0.300
 Why?
Elective Surgical Procedures
1
2011
201
0.300
 Why?
Colorado
12
2019
4564
0.300
 Why?
Antibodies, Antiphospholipid
3
2011
24
0.290
 Why?
Fibrin
3
2022
91
0.290
 Why?
Time Factors
9
2025
7173
0.290
 Why?
Platelet Aggregation
3
2018
105
0.290
 Why?
Psychometrics
2
2019
734
0.290
 Why?
Embolization, Therapeutic
1
2011
242
0.280
 Why?
Chickenpox
2
2001
81
0.280
 Why?
Physical Examination
2
2007
239
0.270
 Why?
Patient Satisfaction
2
2017
704
0.270
 Why?
Antibodies, Neutralizing
3
2016
340
0.270
 Why?
Fibrin Fibrinogen Degradation Products
5
2012
93
0.270
 Why?
Sheep
5
2008
880
0.260
 Why?
Postphlebitic Syndrome
1
2007
2
0.260
 Why?
Protein S
5
2002
11
0.250
 Why?
Sports
1
2009
211
0.250
 Why?
Equipment Contamination
1
2007
71
0.250
 Why?
Models, Animal
1
2008
392
0.250
 Why?
Cross-Sectional Studies
8
2026
5868
0.250
 Why?
Developmental Disabilities
1
2010
281
0.250
 Why?
Europe
2
2025
412
0.240
 Why?
Varicose Ulcer
1
2006
5
0.240
 Why?
Tumor Necrosis Factor-alpha
2
2025
1217
0.230
 Why?
Catheters, Indwelling
3
2005
96
0.230
 Why?
Infection Control
1
2007
172
0.230
 Why?
Recombinant Proteins
5
2015
1370
0.230
 Why?
Qa-SNARE Proteins
1
2025
19
0.230
 Why?
Bacteria, Anaerobic
1
2005
25
0.230
 Why?
Jugular Veins
1
2005
42
0.230
 Why?
Cognition Disorders
1
2010
538
0.230
 Why?
Thrombelastography
4
2018
178
0.230
 Why?
Recurrence
10
2024
1135
0.220
 Why?
Microfluidic Analytical Techniques
2
2017
81
0.220
 Why?
Down-Regulation
2
2025
627
0.220
 Why?
Sepsis
4
2020
640
0.220
 Why?
Ibuprofen
1
2005
84
0.210
 Why?
Brain Injuries
1
2010
507
0.210
 Why?
Hematology
1
2024
21
0.210
 Why?
Knee Joint
2
2024
426
0.210
 Why?
Anti-Inflammatory Agents, Non-Steroidal
2
2018
338
0.210
 Why?
Health Care Surveys
1
2006
539
0.210
 Why?
Plasma
1
2006
225
0.210
 Why?
Incidence
9
2022
2879
0.200
 Why?
Prothrombin
6
2008
25
0.200
 Why?
Infusions, Intravenous
4
2018
423
0.200
 Why?
Amino Acid Substitution
3
2001
304
0.200
 Why?
Thrombectomy
1
2024
78
0.200
 Why?
Prevalence
8
2016
2834
0.200
 Why?
Bacterial Infections
1
2005
246
0.200
 Why?
Phenotype
6
2021
3162
0.190
 Why?
Autoantibodies
2
2001
1501
0.190
 Why?
Follow-Up Studies
10
2022
5408
0.190
 Why?
Autophagy
1
2025
286
0.190
 Why?
Athletic Injuries
1
2009
569
0.190
 Why?
Placenta
2
2023
780
0.190
 Why?
Synovitis
1
2002
33
0.180
 Why?
Clinical Trials as Topic
5
2010
1053
0.180
 Why?
Mutation
10
2015
4089
0.180
 Why?
Partial Thromboplastin Time
3
1999
50
0.180
 Why?
Fetal Blood
4
2014
342
0.180
 Why?
Administration, Oral
1
2024
847
0.170
 Why?
Blood Proteins
3
2001
249
0.170
 Why?
Intracranial Hemorrhages
2
2024
100
0.170
 Why?
Warfarin
4
2012
170
0.170
 Why?
Medical Oncology
1
2024
332
0.170
 Why?
Quality of Health Care
1
2006
691
0.170
 Why?
Cohort Studies
13
2020
5960
0.160
 Why?
Diagnostic Techniques and Procedures
1
2000
19
0.160
 Why?
Heparin Lyase
1
2000
5
0.160
 Why?
Patient Compliance
2
2003
588
0.160
 Why?
Premedication
1
2020
42
0.160
 Why?
Nigeria
1
2020
24
0.160
 Why?
Prognosis
7
2020
4282
0.160
 Why?
Thrombophlebitis
2
1997
12
0.160
 Why?
Neoplasm Proteins
2
2013
442
0.160
 Why?
Blood Specimen Collection
1
2000
38
0.160
 Why?
Platelet Function Tests
2
2017
34
0.160
 Why?
North America
1
2021
310
0.160
 Why?
Fellowships and Scholarships
1
2024
357
0.160
 Why?
Argentina
1
2019
30
0.150
 Why?
Bone Diseases
1
2020
61
0.150
 Why?
Animals, Newborn
1
2002
902
0.150
 Why?
Walking
1
2024
545
0.150
 Why?
Mutation, Missense
1
2001
340
0.150
 Why?
Practice Guidelines as Topic
4
2020
1560
0.150
 Why?
Protein S Deficiency
2
1996
8
0.150
 Why?
Factor XIII
2
2024
15
0.150
 Why?
Magnetic Resonance Imaging
5
2017
3863
0.150
 Why?
Risk
4
2013
911
0.150
 Why?
International Cooperation
2
2013
198
0.140
 Why?
Aged, 80 and over
6
2018
8265
0.140
 Why?
Heart Defects, Congenital
2
2018
914
0.140
 Why?
Ketorolac
1
2018
30
0.140
 Why?
Antibodies
3
2013
401
0.140
 Why?
Platelet Adhesiveness
1
2017
15
0.140
 Why?
Predictive Value of Tests
2
2021
2115
0.140
 Why?
Immune Tolerance
2
2015
379
0.130
 Why?
Hemorheology
1
2017
24
0.130
 Why?
Enzyme-Linked Immunosorbent Assay
3
2014
851
0.130
 Why?
Herpesvirus 3, Human
1
2001
336
0.130
 Why?
Chondroitin Sulfates
1
2017
35
0.130
 Why?
Pediatrics
2
2024
1114
0.130
 Why?
Sensitivity and Specificity
5
2012
1985
0.130
 Why?
Observer Variation
4
2015
355
0.130
 Why?
Arthralgia
1
2017
61
0.130
 Why?
Electrocardiography
2
2018
662
0.130
 Why?
Office Visits
1
2017
90
0.120
 Why?
Secondary Prevention
2
2016
254
0.120
 Why?
Whole Genome Sequencing
1
2017
182
0.120
 Why?
Retrospective Studies
11
2020
17066
0.120
 Why?
Immunoglobulins
1
2016
160
0.120
 Why?
Medication Adherence
2
2017
539
0.120
 Why?
Area Under Curve
3
2011
330
0.120
 Why?
Risk Assessment
4
2011
3671
0.120
 Why?
Fluorescent Antibody Technique
1
2016
370
0.120
 Why?
Kinetics
3
2005
1627
0.110
 Why?
Fetal Proteins
1
1995
15
0.110
 Why?
Blood Coagulation Factor Inhibitors
1
2015
4
0.110
 Why?
Coagulation Protein Disorders
2
2008
2
0.110
 Why?
Cost of Illness
1
2017
321
0.110
 Why?
Residence Characteristics
1
2018
377
0.110
 Why?
Hemostasis, Surgical
2
2011
27
0.110
 Why?
Syndrome
2
2006
380
0.110
 Why?
Models, Biological
4
2024
1821
0.110
 Why?
Ankle Joint
2
2024
122
0.110
 Why?
Renal Veins
1
1994
18
0.110
 Why?
National Heart, Lung, and Blood Institute (U.S.)
1
2014
103
0.110
 Why?
Pregnancy, Animal
1
1994
52
0.110
 Why?
Factor VIIIa
2
2006
4
0.100
 Why?
Muscle, Skeletal
1
2024
1795
0.100
 Why?
Chorioamnionitis
1
2014
45
0.100
 Why?
Contraceptives, Oral, Hormonal
2
2005
30
0.100
 Why?
Spectrum Analysis
2
2005
93
0.100
 Why?
Interleukin-8
1
2014
271
0.100
 Why?
Maternal-Fetal Exchange
1
1994
169
0.100
 Why?
Neoplasms
3
2024
2875
0.100
 Why?
Reference Values
2
2007
797
0.100
 Why?
Randomized Controlled Trials as Topic
2
2010
1720
0.100
 Why?
Fibrin Clot Lysis Time
1
2012
10
0.090
 Why?
Heparin, Low-Molecular-Weight
1
2012
36
0.090
 Why?
Interleukin-1beta
1
2014
395
0.090
 Why?
Hepatitis C
3
2013
254
0.090
 Why?
Migraine with Aura
1
2012
6
0.090
 Why?
Cardiac Surgical Procedures
1
2018
609
0.090
 Why?
Quality Improvement
1
2021
1289
0.090
 Why?
Cytokines
3
2020
2061
0.090
 Why?
Collagen Type I
1
2013
147
0.090
 Why?
Genetic Therapy
2
2005
313
0.090
 Why?
Abdomen
1
2013
141
0.090
 Why?
Polysaccharides
1
2012
87
0.090
 Why?
Canada
2
2003
428
0.090
 Why?
Preoperative Care
2
2011
379
0.090
 Why?
Enoxaparin
1
2012
67
0.090
 Why?
Fatal Outcome
1
2012
307
0.090
 Why?
Nervous System Diseases
1
2014
284
0.090
 Why?
Cerebrovascular Disorders
1
2012
103
0.090
 Why?
Immunomodulation
1
2012
101
0.090
 Why?
Edema
1
2012
124
0.090
 Why?
Research
1
2014
431
0.080
 Why?
Heart Diseases
1
2014
349
0.080
 Why?
Dose-Response Relationship, Drug
3
2016
2027
0.080
 Why?
International Classification of Diseases
1
2011
147
0.080
 Why?
Dependovirus
1
2011
79
0.080
 Why?
Hyperglycemia
1
1994
375
0.080
 Why?
Polymorphism, Genetic
1
2013
612
0.080
 Why?
Myocardial Infarction
1
2018
1209
0.080
 Why?
Interleukin-6
1
2014
780
0.080
 Why?
Phlebography
2
2008
39
0.080
 Why?
Heterozygote
2
2008
315
0.080
 Why?
Pharmacokinetics
1
2009
32
0.080
 Why?
Arm
1
2010
109
0.080
 Why?
Italy
1
2009
113
0.080
 Why?
Moyamoya Disease
1
2009
20
0.070
 Why?
Family Health
1
2010
191
0.070
 Why?
Hepatitis B
3
2013
66
0.070
 Why?
Drug Therapy, Combination
3
2016
1047
0.070
 Why?
Postoperative Care
1
2011
288
0.070
 Why?
Leg
1
2011
239
0.070
 Why?
Recombination, Genetic
1
2010
205
0.070
 Why?
Lower Extremity
1
2013
438
0.070
 Why?
Animals
8
2025
38058
0.070
 Why?
Blindness
1
2008
52
0.070
 Why?
Genotype
1
2013
1833
0.070
 Why?
Transcriptome
1
2015
1045
0.070
 Why?
Inflammation
3
2014
2878
0.070
 Why?
Thromboplastin
2
2013
69
0.070
 Why?
Smoking
1
2015
1472
0.070
 Why?
Cysteine Endopeptidases
2
2013
73
0.070
 Why?
Forecasting
1
2010
391
0.070
 Why?
Research Design
2
2015
1135
0.070
 Why?
Genetic Predisposition to Disease
4
2013
2363
0.070
 Why?
Combined Modality Therapy
1
2011
1266
0.070
 Why?
Antithrombin III
3
1994
17
0.060
 Why?
Infant, Newborn, Diseases
1
2008
113
0.060
 Why?
Overweight
1
2012
609
0.060
 Why?
Drug-Related Side Effects and Adverse Reactions
1
2009
257
0.060
 Why?
Antibodies, Viral
1
2011
672
0.060
 Why?
United States Food and Drug Administration
1
2008
203
0.060
 Why?
Consensus
2
2024
488
0.060
 Why?
Biomechanical Phenomena
2
2024
842
0.060
 Why?
Health Surveys
2
2012
518
0.060
 Why?
History, 20th Century
1
2008
325
0.060
 Why?
Acute Disease
3
2012
1030
0.060
 Why?
Kaplan-Meier Estimate
2
2022
965
0.060
 Why?
Hypertension
1
2015
1263
0.060
 Why?
Logistic Models
4
2015
2117
0.060
 Why?
Data Collection
2
2016
633
0.060
 Why?
Regional Medical Programs
1
2006
6
0.060
 Why?
Blood Coagulation Disorders, Inherited
1
2006
4
0.060
 Why?
Age Distribution
3
2015
403
0.060
 Why?
Elbow Joint
1
2007
74
0.060
 Why?
Health Status Indicators
1
2007
166
0.060
 Why?
Ultrasonography
4
2000
770
0.060
 Why?
Fusobacterium necrophorum
1
2005
2
0.060
 Why?
Fusobacterium Infections
1
2005
7
0.060
 Why?
Pharyngitis
1
2005
25
0.060
 Why?
Computer Simulation
2
2024
1025
0.060
 Why?
Proportional Hazards Models
2
2020
1325
0.050
 Why?
Neuropsychological Tests
1
2010
1134
0.050
 Why?
Glycoproteins
3
1991
355
0.050
 Why?
DNA Mutational Analysis
2
2005
406
0.050
 Why?
Chronic Disease
1
2010
1813
0.050
 Why?
International Normalized Ratio
1
2004
49
0.050
 Why?
Regional Blood Flow
2
2017
514
0.050
 Why?
Muscle Tonus
1
2003
24
0.050
 Why?
Insulin
1
1994
2507
0.050
 Why?
Carboxypeptidase B2
1
2003
2
0.050
 Why?
Serum Globulins
1
2003
5
0.050
 Why?
Remission Induction
1
2004
307
0.050
 Why?
Phosphorus Radioisotopes
1
2002
26
0.050
 Why?
Radiography, Interventional
1
2024
130
0.050
 Why?
Guatemala
1
2024
345
0.050
 Why?
Delivery, Obstetric
1
2024
160
0.050
 Why?
Plasminogen Activator Inhibitor 1
1
2003
84
0.050
 Why?
Automation
1
2003
102
0.050
 Why?
Liver Diseases
1
2006
304
0.050
 Why?
Radionuclide Imaging
1
2002
112
0.050
 Why?
Elbow
1
2002
57
0.050
 Why?
Sex Factors
3
2013
2112
0.050
 Why?
Blood Sedimentation
1
2022
37
0.050
 Why?
Acceleration
1
2022
33
0.050
 Why?
Transfusion Reaction
1
2002
63
0.050
 Why?
Therapeutics
1
2022
13
0.040
 Why?
Knee
1
2002
71
0.040
 Why?
Ankle
1
2002
63
0.040
 Why?
Drug Costs
1
2003
116
0.040
 Why?
Obesity
2
2013
3077
0.040
 Why?
Injections
1
2002
196
0.040
 Why?
Liver Failure, Acute
1
2002
67
0.040
 Why?
Factor X
1
2001
25
0.040
 Why?
Algorithms
2
2011
1837
0.040
 Why?
Hormone Replacement Therapy
1
2002
106
0.040
 Why?
Pregnancy Outcome
1
2005
476
0.040
 Why?
Clinical Laboratory Techniques
1
2002
96
0.040
 Why?
Quality Assurance, Health Care
2
2015
340
0.040
 Why?
Phosphatidylserines
1
2001
60
0.040
 Why?
Body Weight
1
2006
976
0.040
 Why?
Developing Countries
1
2003
318
0.040
 Why?
Diagnostic Imaging
2
2015
338
0.040
 Why?
Hospitalization
1
2011
2433
0.040
 Why?
RNA, Messenger
2
2002
2832
0.040
 Why?
Diagnostic Equipment
1
2000
5
0.040
 Why?
Exercise Therapy
1
2006
473
0.040
 Why?
Polymorphism, Single Nucleotide
1
2008
2145
0.040
 Why?
Diagnosis, Differential
2
2017
1489
0.040
 Why?
Phosphatidylcholines
1
2001
131
0.040
 Why?
Self Care
1
2003
389
0.040
 Why?
Priapism
1
2000
10
0.040
 Why?
Evaluation Studies as Topic
1
2000
166
0.040
 Why?
Statistics as Topic
1
2001
284
0.040
 Why?
Purpura
2
1990
18
0.040
 Why?
False Negative Reactions
1
2000
60
0.040
 Why?
Drug Eruptions
1
2000
28
0.040
 Why?
Vitamin K
2
1999
45
0.040
 Why?
Cardiovascular Diseases
1
2012
2168
0.040
 Why?
Longitudinal Studies
2
2007
2947
0.040
 Why?
Veins
1
2000
68
0.040
 Why?
Quality Control
1
2000
163
0.040
 Why?
Prothrombin Time
1
1999
33
0.040
 Why?
Plethysmography
1
2000
108
0.040
 Why?
HIV Seronegativity
1
1999
29
0.040
 Why?
Gene Expression Regulation, Developmental
1
2005
905
0.040
 Why?
Vasoconstrictor Agents
1
2020
144
0.040
 Why?
False Positive Reactions
1
1999
121
0.040
 Why?
Cost-Benefit Analysis
1
2002
634
0.040
 Why?
Liposomes
1
2001
250
0.040
 Why?
Sheep Diseases
1
1999
9
0.040
 Why?
Comorbidity
2
2015
1658
0.040
 Why?
Disease Progression
1
2007
2847
0.040
 Why?
Motor Activity
1
2003
721
0.040
 Why?
Mitochondria
1
2025
984
0.030
 Why?
Age of Onset
2
2010
551
0.030
 Why?
ROC Curve
1
2020
614
0.030
 Why?
Time-to-Treatment
1
2020
243
0.030
 Why?
Therapeutic Equivalency
1
2018
31
0.030
 Why?
Asia
1
2018
70
0.030
 Why?
Deamino Arginine Vasopressin
1
2017
13
0.030
 Why?
Mice, Knockout
1
2025
3121
0.030
 Why?
Disease Models, Animal
1
2008
4557
0.030
 Why?
Factor VII
2
2013
25
0.030
 Why?
Intensive Care Units, Pediatric
1
2020
285
0.030
 Why?
Bone and Bones
1
2020
314
0.030
 Why?
Postoperative Period
1
2018
354
0.030
 Why?
Chromosome Disorders
1
1997
45
0.030
 Why?
Drug Resistance
1
1997
153
0.030
 Why?
Chromosome Aberrations
1
1997
162
0.030
 Why?
Pedigree
2
1996
514
0.030
 Why?
Arginine
1
1997
262
0.030
 Why?
Comparative Genomic Hybridization
1
2016
28
0.030
 Why?
Blood Flow Velocity
1
2017
413
0.030
 Why?
Injections, Subcutaneous
1
2016
164
0.030
 Why?
Models, Theoretical
1
2019
582
0.030
 Why?
Erythrocytes
1
2022
757
0.030
 Why?
Odds Ratio
2
2013
1075
0.030
 Why?
Patient-Centered Care
1
2021
544
0.030
 Why?
Plasmapheresis
1
2015
22
0.030
 Why?
Streptococcus pyogenes
1
1996
41
0.030
 Why?
Intracranial Embolism and Thrombosis
1
1995
7
0.030
 Why?
Decision Making
1
2003
975
0.030
 Why?
Stress, Mechanical
1
2017
494
0.030
 Why?
Cross-Over Studies
1
2018
601
0.030
 Why?
Models, Immunological
1
2015
100
0.030
 Why?
Florida
1
2015
117
0.030
 Why?
Embryonic and Fetal Development
1
1995
93
0.030
 Why?
Respiration, Artificial
1
2020
708
0.030
 Why?
Endpoint Determination
1
2015
83
0.030
 Why?
Causality
1
2015
126
0.030
 Why?
Parents
1
2003
1403
0.030
 Why?
Single-Blind Method
1
2015
312
0.030
 Why?
Sex Distribution
1
2015
386
0.030
 Why?
Neuroimaging
1
2016
289
0.030
 Why?
Polymerase Chain Reaction
1
1997
1054
0.030
 Why?
Factor VIIa
1
2013
43
0.030
 Why?
Propensity Score
1
2015
367
0.020
 Why?
Streptococcal Infections
1
1996
168
0.020
 Why?
Public Health Surveillance
1
2013
83
0.020
 Why?
Microfluidics
1
2013
62
0.020
 Why?
Gestational Age
2
2014
975
0.020
 Why?
Sequence Analysis, DNA
1
2016
824
0.020
 Why?
Mice
2
2025
18339
0.020
 Why?
Vena Cava, Inferior
1
2013
81
0.020
 Why?
Immunoglobulin G
1
2016
893
0.020
 Why?
Heparin Cofactor II
1
1991
1
0.020
 Why?
Horses
1
2013
201
0.020
 Why?
Chi-Square Distribution
1
2013
529
0.020
 Why?
Parvoviridae Infections
1
2011
12
0.020
 Why?
Homozygote
3
2003
199
0.020
 Why?
Cardiology
1
2014
353
0.020
 Why?
Protein Deficiency
1
1990
4
0.020
 Why?
Seroepidemiologic Studies
1
2011
172
0.020
 Why?
Feasibility Studies
1
2015
1095
0.020
 Why?
Complement Inactivator Proteins
1
1990
39
0.020
 Why?
Immunosuppressive Agents
1
2015
846
0.020
 Why?
Genetic Variation
1
2016
983
0.020
 Why?
Carrier Proteins
2
1991
737
0.020
 Why?
Liver
2
1999
1887
0.020
 Why?
Health Status Disparities
1
2013
321
0.020
 Why?
Delphi Technique
1
2011
329
0.020
 Why?
Genetic Vectors
1
2011
337
0.020
 Why?
Perioperative Care
1
2012
231
0.020
 Why?
Pilot Projects
1
2015
1886
0.020
 Why?
Molecular Weight
1
1989
327
0.020
 Why?
Multivariate Analysis
1
2013
1539
0.020
 Why?
Glucose
1
1994
1047
0.020
 Why?
Germany
1
2009
138
0.020
 Why?
Recovery of Function
1
2013
707
0.020
 Why?
Multicenter Studies as Topic
1
2009
405
0.020
 Why?
C-Reactive Protein
1
2009
416
0.020
 Why?
Twins
1
1988
156
0.020
 Why?
Vitamin K Deficiency
1
1986
9
0.020
 Why?
Evidence-Based Medicine
1
2010
732
0.020
 Why?
Polycystic Kidney Diseases
1
1987
71
0.020
 Why?
Kidney
1
1994
1495
0.010
 Why?
Protein Precursors
1
1986
137
0.010
 Why?
Endopeptidases
1
1986
82
0.010
 Why?
Cell Line
1
2011
2882
0.010
 Why?
Global Health
1
2008
401
0.010
 Why?
Postoperative Complications
1
1997
2919
0.010
 Why?
Wounds and Injuries
1
2013
956
0.010
 Why?
Body Mass Index
1
2013
2438
0.010
 Why?
Introns
1
2005
254
0.010
 Why?
Aging
1
1995
1966
0.010
 Why?
Exons
1
2005
358
0.010
 Why?
Antibody Formation
1
2005
294
0.010
 Why?
HIV Infections
2
2013
3154
0.010
 Why?
Abortion, Habitual
1
2002
4
0.010
 Why?
Arterial Occlusive Diseases
1
2003
90
0.010
 Why?
Acquired Immunodeficiency Syndrome
1
2001
235
0.010
 Why?
Necrosis
1
2000
244
0.010
 Why?
Factor X Deficiency
1
1999
3
0.010
 Why?
Counterimmunoelectrophoresis
1
1999
3
0.010
 Why?
Thrombin Time
1
1999
11
0.010
 Why?
Genes, Recessive
1
1999
78
0.010
 Why?
Immunoelectrophoresis, Two-Dimensional
2
1990
4
0.010
 Why?
Blotting, Western
1
2000
1187
0.010
 Why?
Base Sequence
1
2000
2190
0.010
 Why?
Molecular Sequence Data
1
2000
2930
0.010
 Why?
Urography
1
1987
19
0.000
 Why?
Genes, Dominant
1
1987
101
0.000
 Why?
Infant, Small for Gestational Age
1
1986
109
0.000
 Why?
Serine Endopeptidases
1
1986
128
0.000
 Why?
Protein Binding
1
1986
2273
0.000
 Why?
Manco-Johnson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (497) concept(s)
_
Co-Authors Expand Description
See all (40) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)